These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7945002)

  • 41. [Efficacy, safety and effect on the quality of life of gabapentin in adult epilepsy--results of a prospective open-label quasi naturalistic Hungarian multicenter study (phase human-IV)].
    Rajna P; Szíjártó E
    Ideggyogy Sz; 2006 Sep; 59(9-10):361-72. PubMed ID: 17165379
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of partial seizures with gabapentin: double-blind, placebo-controlled, parallel-group study.
    Yamauchi T; Kaneko S; Yagi K; Sase S
    Psychiatry Clin Neurosci; 2006 Aug; 60(4):507-15. PubMed ID: 16884455
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of gabapentin (Neurontin) [corrected] on mood and well-being in patients with epilepsy.
    Dimond KR; Pande AC; Lamoreaux L; Pierce MW
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 Apr; 20(3):407-17. PubMed ID: 8771597
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dosing to efficacy with neurontin: the STEPS trial. Study of Titration to Effect Profile of Safety.
    Morrell MJ
    Epilepsia; 1999; 40 Suppl 6():S23-6; discussion S73-4. PubMed ID: 10530679
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of gabapentin on cognition and quality of life in patients with epilepsy.
    Mortimore C; Trimble M; Emmers E
    Seizure; 1998 Oct; 7(5):359-64. PubMed ID: 9808110
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of gabapentin as an add-on therapy in refractory partial epileptic patients.
    Towanabut S; Rungreangyingyod L; Suthisisang C
    J Med Assoc Thai; 2001 Apr; 84(4):554-61. PubMed ID: 11460968
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An audit of the perceived efficacy and tolerability of gabapentin therapy in an out-patient cohort with chronic epilepsy.
    Langan Y; Duncan JS; Sander JW
    Eur Neurol; 1999; 41(2):111-3. PubMed ID: 10023116
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gabapentin (NEURONTIN)--a novel anticonvulsant.
    Murdoch LA
    Axone; 1994 Dec; 16(2):56. PubMed ID: 7727298
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gabapentin treatment of seizures in acute intermittent porphyria.
    Tatum WO; Zachariah SB
    Neurology; 1995 Jun; 45(6):1216-7. PubMed ID: 7783893
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Efficacy and tolerability of dose-escalation with generic gabapentin--a multicenter, non-interventional study].
    Rejdak K; Lipa A; Kaczyński K; Stelmasiak Z;
    Wiad Lek; 2011; 64(2):91-6. PubMed ID: 22026272
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Add-on gabapentin for refractory seizures in patients with brain tumours.
    Perry JR; Sawka C
    Can J Neurol Sci; 1996 May; 23(2):128-31. PubMed ID: 8738926
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. 1993.
    Neurology; 2001 Dec; 57(11 Suppl 4):S62-8. PubMed ID: 11775611
    [No Abstract]   [Full Text] [Related]  

  • 53. Gabapentin to control seizures in children undergoing cancer treatment.
    Khan RB; Hunt DL; Thompson SJ
    J Child Neurol; 2004 Feb; 19(2):97-101. PubMed ID: 15072101
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New antiepileptic drugs: a systematic review of their efficacy and tolerability.
    Marson AG; Kadir ZA; Chadwick DW
    BMJ; 1996 Nov; 313(7066):1169-74. PubMed ID: 8916746
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A study of gabapentin in the treatment of tonic-clonic seizures of alcohol withdrawal syndrome.
    Rustembegovic A; Sofic E; Tahirović I; Kundurović Z
    Med Arh; 2004; 58(1):5-6. PubMed ID: 15017894
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Refractory epilepsy: treatment with new antiepileptic drugs.
    Datta PK; Crawford PM
    Seizure; 2000 Jan; 9(1):51-7. PubMed ID: 10667964
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.
    Backonja M; Beydoun A; Edwards KR; Schwartz SL; Fonseca V; Hes M; LaMoreaux L; Garofalo E
    JAMA; 1998 Dec; 280(21):1831-6. PubMed ID: 9846777
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Gabapentin used in 559 patients with partial seizures. A multicenter observation study. Spanish Gabapentin Work Group].
    Herranz JL; Sol JM; Hernández G
    Rev Neurol; 2000 Jun 16-30; 30(12):1141-5. PubMed ID: 10935239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cognitive abilities and adjustment with gabapentin: results of a multisite study.
    Dodrill CB; Arnett JL; Hayes AG; Garofalo EA; Greeley CA; Greiner MJ; Pierce MW
    Epilepsy Res; 1999 Jun; 35(2):109-21. PubMed ID: 10372564
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gabapentin.
    Chadwick D
    Lancet; 1994 Jan; 343(8889):89-91. PubMed ID: 7903783
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.